{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:31:54Z","timestamp":1795033914061,"version":"4.10.2"},"posted":{"date-parts":[[2026,2,19]]},"group-title":"In Review","reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,12]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Group 3 medulloblastoma (G3MB) is a devastating disease of the central nervous system (CNS) that primarily affects infants and children. Chimeric antigen receptor (CAR) T cell therapy holds the promise to improve outcomes for CNS malignancies, but few studies have focused specifically on G3MB. We used publicly available datasets to demonstrate EphA2 and B7-H3 expression in primary G3MB and validated expression in patient-derived cell lines. EphA2-CAR T cells had greater cytolytic activity, persistence, and TH1 cytokine production than B7-H3-CAR T cells in coculture assays with MYC-driven G3MB cell lines\n                  <italic>in vitro<\/italic>\n                  .\n                  <italic>In vivo<\/italic>\n                  , EphA2-CAR T cells demonstrated superior tumor control and improved survival compared to B7-H3-CAR T cells in 2 of 3 orthotopic G3MB models. B7-H3-CAR T cells outperformed EphA2-CAR T cells in one model in which the antigen density of EphA2 was 5-fold lower than for B7-H3. The limited antitumor activity of EphA2-CAR T cells could be overcome with second genetic modifications that increase T cell functionality including deletion of\n                  <italic>DNMT3A<\/italic>\n                  or the expression of a constitutively active IL-18 chimeric cytokine receptor. Thus, our study nominates EphA2-CAR T cells as a promising alternative to B7-H3-CAR T cells, which are actively being explored in clinical studies for medulloblastoma.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8863171\/v1","type":"posted-content","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:38:39Z","timestamp":1771504719000},"source":"Crossref","is-referenced-by-count":1,"title":["Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 Medulloblastoma"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-9713","authenticated-orcid":false,"given":"Meghan","family":"Ward","sequence":"first","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Fouliard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Meehl","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5179-2412","authenticated-orcid":false,"given":"Diana","family":"Dinh","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ibanez-Vega","sequence":"additional","affiliation":[{"name":"St Jude Childrens Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-8382","authenticated-orcid":false,"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-8139","authenticated-orcid":false,"given":"Martine","family":"Roussel","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-4429","authenticated-orcid":false,"given":"Jiyang","family":"Yu","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-7468","authenticated-orcid":false,"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4335-0644","authenticated-orcid":false,"given":"Giedre","family":"Krenciute","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/children10010062","author":"Kulubya ES","year":"2022","unstructured":"Kulubya ES, Kercher MJ, Phillips HW, Antony R, Edwards MSB (2022) Advances in the Treatment of Pediatric Brain Tumors. Children (Basel). ;10(1). Epub 20221227. 10.3390\/children10010062. PubMed PMID: 36670613; PMCID: PMC9856380"},{"issue":"9","key":"ref2","doi-asserted-by":"publisher","first-page":"101796","DOI":"10.1016\/j.adro.2025.101796","article-title":"Treatment Outcomes and Prognostic Factors for Patients With Medulloblastoma Having Defined Molecular Subtypes","volume":"10","author":"Shi X","year":"2025","unstructured":"Shi X, Liu S, Sun X, Li Y, Jiang M (2025) Treatment Outcomes and Prognostic Factors for Patients With Medulloblastoma Having Defined Molecular Subtypes. Adv Radiat Oncol 10(9):101796 Epub 20250627. 10.1016\/j.adro.2025.101796","journal-title":"Adv Radiat Oncol"},{"issue":"8046","key":"ref3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje M","year":"2025","unstructured":"Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM, Barsan V, Song K-W, Kamens J, Baggott C, Kunicki M, Rietberg SP, Lim AS, Reschke A, Mavroukakis S, Egeler E, Moon J, Patel S, Chinnasamy H, Erickson C, Jacobs A, Duh AK, Tunuguntla R, Klysz DD, Fowler C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK, Petersen A-LG, McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham K, Bove R, Musa E, Reynolds WD, Kuo A, Prabhu S, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye X, Sahaf B, Davis KL, Feldman SA, Ramakrishna S, Mackall C (2025) Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas. Nature 637(8046):708\u2013715. 10.1038\/s41586-024-08171-9","journal-title":"Nature"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza NA","year":"2025","unstructured":"Vitanza NA, Ronsley R, Choe M, Seidel K, Huang W, Rawlings-Rhea SD, Beam M, Steinmetzer L, Wilson AL, Brown C, Beebe A, Lindgren C, Gustafson JA, Wein A, Holtzclaw S, Hoeppner C, Goldstein HE, Browd SR, Hauptman JS, Lee A, Ojemann JG, Crotty EE, Leary SES, Perez FA, Wright JN, Alonso MM, Dun MD, Foster JB, Hurst D, Kong A, Thomsen A, Orentas RJ, Albert CM, Pinto N, Annesley C, Gardner RA, Ho O, Pattabhi S, Gust J, Wendler JP, Park JR, Jensen MC (2025) Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial. Nat Med 31(3):861\u2013868. 10.1038\/s41591-024-03451-3","journal-title":"Nat Med"},{"issue":"8","key":"ref5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neurol.2025.07.005","article-title":"Literature review: CAR T-cell therapy as a promising immunotherapeutic approach for medulloblastoma","volume":"181","author":"Eksteen C","year":"2025","unstructured":"Eksteen C, Riedemann J, Johnson H, Engelbrecht AM (2025) Literature review: CAR T-cell therapy as a promising immunotherapeutic approach for medulloblastoma. Rev Neurol 181(8):703\u2013712. https:\/\/doi.org\/10.1016\/j.neurol.2025.07.005","journal-title":"Rev Neurol"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"201067","DOI":"10.1016\/j.omton.2025.201067","article-title":"GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts","volume":"33","author":"Okada R","year":"2025","unstructured":"Okada R, Fanuzzi M, Rodriguez C, Oh J, Sreenivasan A, Stack HG, Puebla M, Phadke I, Cole AP, Bradford S, Kelly MC, Lei H, Ho M, Cotter JA, Thiele CJ, Zhang X, Nellan A, Nguyen R (2025) GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts. Mol Ther Oncol 33(4):201067 Epub 20250930. 10.1016\/j.omton.2025.201067","journal-title":"Mol Ther Oncol"},{"issue":"6","key":"ref7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/neuonc\/noaa278","article-title":"Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery","volume":"23","author":"Haydar D","year":"2021","unstructured":"Haydar D, Houke H, Chiang J, Yi Z, Od\u00e9 Z, Caldwell K, Zhu X, Mercer KS, Stripay JL, Shaw TI, Vogel P, DeRenzo C, Baker SJ, Roussel MF, Gottschalk S, Krenciute G (2021) Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Neuro Oncol 23(6):999\u20131011. 10.1093\/neuonc\/noaa278PubMed PMID: 33320196; PMCID: PMC8168826","journal-title":"Neuro Oncol"},{"issue":"8","key":"ref8","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.Ccr-18-0432","article-title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","volume":"25","author":"Majzner RG","year":"2019","unstructured":"Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM, Mackall CL (2019) CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clin Cancer Res 25(8):2560\u20132574 Epub 20190117. 10.1158\/1078-0432.Ccr-18-0432","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40425-018-0340-z","article-title":"Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells","volume":"6","author":"Nellan A","year":"2018","unstructured":"Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW (2018) Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer 6(1):30. 10.1186\/s40425-018-0340-z","journal-title":"J Immunother Cancer"},{"issue":"11","key":"ref10","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1158\/1078-0432.Ccr-23-1880","article-title":"GD2-Targeting CAR T-cell Therapy for Patients with GD2\u2009+\u2009Medulloblastoma","volume":"30","author":"Ciccone R","year":"2024","unstructured":"Ciccone R, Quintarelli C, Camera A, Pezzella M, Caruso S, Manni S, Ottaviani A, Guercio M, Del Bufalo F, Quadraccia MC, Orlando D, Di Cecca S, Sinibaldi M, Aurigemma M, Iaffaldano L, Sarcinelli A, D'Amore ML, Ceccarelli M, Nazio F, Marabitti V, Giorda E, Pezzullo M, De Stefanis C, Carai A, Rossi S, Alaggio R, Del Baldo G, Becilli M, Mastronuzzi A, De Angelis B, Locatelli F (2024) GD2-Targeting CAR T-cell Therapy for Patients with GD2\u2009+\u2009Medulloblastoma. Clin Cancer Res 30(11):2545\u20132557. 10.1158\/1078-0432.Ccr-23-1880PubMed PMID: 38551501; PMCID: PMC11145172","journal-title":"Clin Cancer Res"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","article-title":"Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma","volume":"26","author":"Donovan LK","year":"2020","unstructured":"Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM, Haapasalo J, Nor C, Vladoiu MC, Kuzan-Fischer CM, Garzia L, Mack SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG, Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M, Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen PH, Ahmed N, Taylor MD (2020) Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med 26(5):720\u2013731. 10.1038\/s41591-020-0827-2","journal-title":"Nat Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"2485535","DOI":"10.1080\/2162402X.2025.2485535","article-title":"EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by \u03b3\u03b4T cells preserves neuronal and stem cell integrity","volume":"14","author":"Boutin L","year":"2025","unstructured":"Boutin L, Liu M, D\u00e9chanet Merville J, Bedoya-Reina O, Wilhelm MT (2025) EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by \u03b3\u03b4T cells preserves neuronal and stem cell integrity. Oncoimmunology 14(1):2485535 2485535. PubMed PMID: 40190167; PMCID: PMC11980450","journal-title":"Oncoimmunology"},{"issue":"7409","key":"ref13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson G","year":"2012","unstructured":"Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, Phoenix TN, Hedlund E, Wei L, Zhu X, Chalhoub N, Baker SJ, Huether R, Kriwacki R, Curley N, Thiruvenkatam R, Wang J, Wu G, Rusch M, Hong X, Becksfort J, Gupta P, Ma J, Easton J, Vadodaria B, Onar-Thomas A, Lin T, Li S, Pounds S, Paugh S, Zhao D, Kawauchi D, Roussel MF, Finkelstein D, Ellison DW, Lau CC, Bouffet E, Hassall T, Gururangan S, Cohn R, Fulton RS, Fulton LL, Dooling DJ, Ochoa K, Gajjar A, Mardis ER, Wilson RK, Downing JR, Zhang J, Gilbertson RJ (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488(7409):43\u201348. 10.1038\/nature11213","journal-title":"Nature"},{"issue":"7409","key":"ref14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature11327","article-title":"Subgroup-specific structural variation across 1,000 medulloblastoma genomes","volume":"488","author":"Northcott PA","year":"2012","unstructured":"Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, St\u00fctz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, Dubuc A, Yao Y, Ramaswamy V, Luu B, Rolider A, Cavalli FM, Wang X, Remke M, Wu X, Chiu RY, Chu A, Chuah E, Corbett RD, Hoad GR, Jackman SD, Li Y, Lo A, Mungall KL, Nip KM, Qian JQ, Raymond AG, Thiessen NT, Varhol RJ, Birol I, Moore RA, Mungall AJ, Holt R, Kawauchi D, Roussel MF, Kool M, Jones DT, Witt H, Fernandez LA, Kenney AM, Wechsler-Reya RJ, Dirks P, Aviv T, Grajkowska WA, Perek-Polnik M, Haberler CC, Delattre O, Reynaud SS, Doz FF, Pernet-Fattet SS, Cho BK, Kim SK, Wang KC, Scheurlen W, Eberhart CG, F\u00e8vre-Montange M, Jouvet A, Pollack IF, Fan X, Muraszko KM, Gillespie GY, Di Rocco C, Massimi L, Michiels EM, Kloosterhof NK, French PJ, Kros JM, Olson JM, Ellenbogen RG, Zitterbart K, Kren L, Thompson RC, Cooper MK, Lach B, McLendon RE, Bigner DD, Fontebasso A, Albrecht S, Jabado N, Lindsey JC, Bailey S, Gupta N, Weiss WA, Bogn\u00e1r L, Klekner A, Van Meter TE, Kumabe T, Tominaga T, Elbabaa SK, Leonard JR, Rubin JB, Liau LM, Van Meir EG, Fouladi M, Nakamura H, Cinalli G, Garami M, Hauser P, Saad AG, Iolascon A, Jung S, Carlotti CG, Vibhakar R, Ra YS, Robinson S, Zollo M, Faria CC, Chan JA, Levy ML, Sorensen PH, Meyerson M, Pomeroy SL, Cho YJ, Bader GD, Tabori U, Hawkins CE, Bouffet E, Scherer SW, Rutka JT, Malkin D, Clifford SC, Jones SJ, Korbel JO, Pfister SM, Marra MA, Taylor MD (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488(7409):49\u201356. 10.1038\/nature11327PubMed PMID: 22832581; PMCID: PMC3683624","journal-title":"Nature"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1215\/15228517-2008-032","article-title":"Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis","volume":"10","author":"Bont JM","year":"2008","unstructured":"de Bont JM, Kros JM, Passier MMCJ, Reddingius RE, Smitt PAES, Luider TM, Boer MLd, Pieters R (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neurooncology 10(5):648\u2013660. 10.1215\/15228517-2008-032","journal-title":"Neurooncology"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/s41467-023-38335-6","article-title":"NetBID2 provides comprehensive hidden driver analysis","volume":"14","author":"Dong X","year":"2023","unstructured":"Dong X, Ding L, Thrasher A, Wang X, Liu J, Pan Q, Rash J, Dhungana Y, Yang X, Risch I, Li Y, Yan L, Rusch M, McLeod C, Yan K-K, Peng J, Chi H, Zhang J, Yu J (2023) NetBID2 provides comprehensive hidden driver analysis. Nat Commun 14(1):2581. 10.1038\/s41467-023-38335-6","journal-title":"Nat Commun"},{"key":"ref17","author":"Cavalli FMG","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, L\u00f3pez-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpe\u00f1a-Diazconti M, Chico Ponce de Le\u00f3n F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD (2017) Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. ;31(6):737\u2009\u2013\u200954.e6. doi: 10.1016\/j.ccell.2017.05.005. PubMed PMID: 28609654; PMCID: PMC6163053"},{"issue":"7663","key":"ref18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott PA","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gr\u00f6bner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, J\u00e4ger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, J\u00e4ger-Schmidt C, Imbusch CD, Jugold A, H\u00fcbschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547(7663):311\u2013317. 10.1038\/nature22973PubMed PMID: 28726821; PMCID: PMC5905700","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.omtm.2018.01.009","article-title":"Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma","volume":"9","author":"Yi Z","year":"2018","unstructured":"Yi Z, Prinzing BL, Cao F, Gottschalk S, Krenciute G (2018) Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma. Mol Ther Methods Clin Dev 9:70\u201380 Epub 20180202. 10.1016\/j.omtm.2018.01.009","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref20","first-page":"202","article-title":"Route of 41BB\/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28\u03b6 T Cells. Molecular therapy oncolytics","volume":"18","author":"Nguyen P","year":"2020","unstructured":"Nguyen P, Okeke E, Clay M, Haydar D, Justice J, O'Reilly C, Pruett-Miller S, Papizan J, Moore J, Zhou S, Throm R, Krenciute G, Gottschalk S, DeRenzo C (2020) Route of 41BB\/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28\u03b6 T Cells. Molecular therapy oncolytics. 18:202\u2013214 .018. PubMed PMID: 32728609; PMCID: PMC7369352"},{"issue":"Supplement5","key":"ref21","doi-asserted-by":"publisher","first-page":"v148","DOI":"10.1093\/neuonc\/noaf201.0585","article-title":"CTP-13. Locoregional B7-H3 CAR-T cells for relapsed\/refractory CNS tumors: preliminary clinical experience of the Loc3CAR trial","volume":"27","author":"Bertrand K","year":"2025","unstructured":"Bertrand K, Hanzlik E, Chiang J, Pinto S, Selukar S, Kosteka A, Smith K, Han K, Ibanez J, Tlais D, Orr B, Langfitt D, Metais J-Y, Lockey T, Willis C, Fazio F, Shanmugmam R, Tian L, Walhart T, Wang Y, Allmon P, Perry S, Schell S, Adams P, Ward M, Meehl M, Akel S, Poston L, Bag A, Mack S, Klimo P, Gajjar A, Thomas P, Crawford J, Robinson G, Park J, Northcott P, Gottschalk S, Krenciute G, DeRenzo C (2025) CTP-13. Locoregional B7-H3 CAR-T cells for relapsed\/refractory CNS tumors: preliminary clinical experience of the Loc3CAR trial. Neurooncology 27(Supplement5):v148\u2013v. 10.1093\/neuonc\/noaf201.0585","journal-title":"Neurooncology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1034257","DOI":"10.3389\/fcell.2022.1034257","article-title":"Mechanisms of CAR T cell exhaustion and current counteraction strategies","volume":"10","author":"Zhu X","year":"2022","unstructured":"Zhu X, Li Q, Zhu X (2022) Mechanisms of CAR T cell exhaustion and current counteraction strategies. Front Cell Dev Biol 10:1034257 Epub 20221208. 10.3389\/fcell.2022.1034257","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"ref23","doi-asserted-by":"publisher","first-page":"e70345","DOI":"10.1002\/ctm2.70345","article-title":"Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy","volume":"15","author":"Xiang S","year":"2025","unstructured":"Xiang S, Li S, Xu J (2025) Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy. Clin Transl Med 15(5):e70345. 10.1002\/ctm2.70345PubMed PMID: 40415479; PMCID: PMC12104568","journal-title":"Clin Transl Med"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"Distinct functions in immune regulation","volume":"57","author":"Joller N","year":"2024","unstructured":"Joller N, Anderson AC, Kuchroo VK, LAG-3 TIM-3 (2024) Distinct functions in immune regulation. Immunity 57(2):206\u2013222. 10.1016\/j.immuni.2024.01.010PubMed PMID: 38354701; PMCID: PMC10919259","journal-title":"Immunity"},{"issue":"21","key":"ref25","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood-2014-09-603357","article-title":"B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality","volume":"125","author":"Veenstra RG","year":"2015","unstructured":"Veenstra RG, Flynn R, Kreymborg K, McDonald-Hyman C, Saha A, Taylor PA, Osborn MJ, Panoskaltsis-Mortari A, Schmitt-Graeff A, Lieberknecht E, Murphy WJ, Serody JS, Munn DH, Freeman GJ, Allison JP, Mak TW, van den Brink M, Zeiser R, Blazar BR (2015) B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood 125(21):3335\u20133346 Epub 20150326. 10.1182\/blood-2014-09-603357","journal-title":"Blood"},{"issue":"17","key":"ref26","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1158\/1078-0432.Ccr-24-3083","article-title":"B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response","volume":"31","author":"Mehta S","year":"2025","unstructured":"Mehta S, Ippagunta S, Varadharajan S, Kardian A, Laboe N, Dinh D, Jones AB, Meehl MM, Iba\u00f1ez J, Emanus E, Dao T, Ward MB, Orisme W, Lange S, Langfitt D, Steinberg J, Chiang J, Vogel P, Sheppard H, Ellison DW, Mack SC, Krenciute G (2025) B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. Clin Cancer Res 31(17):3754\u20133770. 10.1158\/1078-0432.Ccr-24-3083PubMed PMID: 40586675; PMCID: PMC12402791","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref27","doi-asserted-by":"publisher","first-page":"101297","DOI":"10.1016\/j.xcrm.2023.101297","article-title":"GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells","volume":"4","author":"Ibanez J","year":"2023","unstructured":"Ibanez J, Hebbar N, Thanekar U, Yi Z, Houke H, Ward M, Nevitt C, Tian L, Mack SC, Sheppard H, Chiang J, Velasquez MP, Krenciute G (2023) GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. Cell Rep Med 4(11):101297 Epub 2023\/11\/23. 10.1016\/j.xcrm.2023.101297","journal-title":"Cell Rep Med"},{"issue":"21","key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136093","article-title":"MyD88\/CD40 signaling retains CAR T cells in a less differentiated state","volume":"5","author":"Prinzing B","year":"2020","unstructured":"Prinzing B, Schreiner P, Bell M, Fan Y, Krenciute G, Gottschalk S (2020) MyD88\/CD40 signaling retains CAR T cells in a less differentiated state. JCI insight 5(21). 10.1172\/jci.insight.136093","journal-title":"JCI insight"},{"issue":"620","key":"ref29","doi-asserted-by":"publisher","first-page":"eabh0272","DOI":"10.1126\/scitranslmed.abh0272","article-title":"Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity","volume":"13","author":"Prinzing B","year":"2021","unstructured":"Prinzing B, Zebley CC, Petersen CT, Fan Y, Anido AA, Yi Z, Nguyen P, Houke H, Bell M, Haydar D, Brown C, Boi SK, Alli S, Crawford JC, Riberdy JM, Park JJ, Zhou S, Velasquez MP, DeRenzo C, Lazzarotto CR, Tsai SQ, Vogel P, Pruett-Miller SM, Langfitt DM, Gottschalk S, Youngblood B, Krenciute G (2021) Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity. Sci Transl Med 13(620):eabh0272. 10.1126\/scitranslmed.abh0272","journal-title":"Sci Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-023-01143-w","article-title":"Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK\/STAT signalling","author":"Bell M","year":"2023","unstructured":"Bell M, Lange S, Sejdiu BI, Ibanez J, Shi H, Sun X, Meng X, Nguyen P, Sutton M, Wagner J, Kc A, Langfitt D, Patil SL, Tan H, Pandey RV, Li Y, Yuan Z-F, Anido AA, Ho M, Sheppard H, Vogel P, Yu J, Peng J, Chi H, Babu MM, Krenciute G, Gottschalk S (2023) Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK\/STAT signalling. Nat Biomedical Eng. 10.1038\/s41551-023-01143-w","journal-title":"Nat Biomedical Eng"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009743","author":"Wickman E","year":"2024","unstructured":"Wickman E, Lange S, Wagner J, Ibanez J, Tian L, Lu M, Sheppard H, Chiang J, Koo SC, Vogel P, Langfitt D, Perry SS, Shanmugam R, Bell M, Shaw TI, Krenciute G, Zhang J, Gottschalk S (2024) IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors. Journal for immunotherapy of cancer. ;12(11). Epub 20241120. 10.1136\/jitc-2024-009743. PubMed PMID: 39572158; PMCID: PMC11580246"},{"issue":"12","key":"ref32","doi-asserted-by":"publisher","first-page":"e50819","DOI":"10.1371\/journal.pone.0050819","article-title":"Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma","volume":"7","author":"Nordberg J","year":"2012","unstructured":"Nordberg J, Mpindi JP, Iljin K, Pulliainen AT, Kallajoki M, Kallioniemi O, Elenius K, Elenius V (2012) Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma. PLoS ONE 7(12):e50819. 10.1371\/journal.pone.0050819","journal-title":"PLoS ONE"},{"issue":"10","key":"ref33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1541-7786.MCR-05-0056","article-title":"EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme","volume":"3","author":"Wykosky J","year":"2005","unstructured":"Wykosky J, Gibo DM, Stanton C, Debinski W (2005) EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme. Mol Cancer Res 3(10):541\u2013551. 10.1158\/1541-7786.MCR-05-0056","journal-title":"Mol Cancer Res"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/onc.2013.590","article-title":"EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties","volume":"34","author":"Miao H","year":"2015","unstructured":"Miao H, Gale NW, Guo H, Qian J, Petty A, Kaspar J, Murphy AJ, Valenzuela DM, Yancopoulos G, Hambardzumyan D, Lathia JD, Rich JN, Lee J, Wang B (2015) EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties. Oncogene 34(5):558\u2013567 Epub 20140203. 10.1038\/onc.2013.590","journal-title":"Oncogene"},{"issue":"1","key":"ref35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-021-00855-2","article-title":"EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma","volume":"7","author":"Gai Q-J","year":"2022","unstructured":"Gai Q-J, Fu Z, He J, Mao M, Yao X-X, Qin Y, Lan X, Zhang L, Miao J-Y, Wang Y-X, Zhu J, Yang F-C, Lu H-M, Yan Z-X, Chen F-L, Shi Y, Ping Y-F, Cui Y-H, Zhang X, Liu X, Yao X-H, Lv S-Q, Bian X-W, Wang Y (2022) EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. Signal Transduct Target Therapy 7(1):33. 10.1038\/s41392-021-00855-2","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"ref36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-012-0998-x","article-title":"Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy","volume":"111","author":"Yeung JT","year":"2013","unstructured":"Yeung JT, Hamilton RL, Okada H, Jakacki RI, Pollack IF (2013) Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy. J Neurooncol 111(2):103\u2013111 Epub 20121121. 10.1007\/s11060-012-0998-x","journal-title":"J Neurooncol"},{"issue":"3","key":"ref37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","article-title":"Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers","volume":"50","author":"Hafner C","year":"2004","unstructured":"Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, Dietmaier W, Landthaler M, Vogt T (2004) Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers. Clin Chem 50(3):490\u2013499. 10.1373\/clinchem.2003.026849","journal-title":"Clin Chem"},{"issue":"11","key":"ref38","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.molimm.2006.12.019","article-title":"Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties","volume":"44","author":"Damschroder MM","year":"2007","unstructured":"Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall\u2019Acqua WF, Wu H (2007) Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties. Mol Immunol 44(11):3049\u20133060. https:\/\/doi.org\/10.1016\/j.molimm.2006.12.019","journal-title":"Mol Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"694941","DOI":"10.3389\/fonc.2021.694941","article-title":"First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose","volume":"11","author":"Lin Q","year":"2021","unstructured":"Lin Q, Ba T, Ho J, Chen D, Cheng Y, Wang L, Xu G, Xu L, Zhou Y, Wei Y, Li J, Ling F (2021) First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose. Front Oncol 11:694941 Epub 20210621. 10.3389\/fonc.2021.694941","journal-title":"Front Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1284293","DOI":"10.3389\/fimmu.2023.1284293","article-title":"The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease","volume":"14","author":"Guo L","year":"2023","unstructured":"Guo L, Liu X, Su X (2023) The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease. Front Immunol 14:1284293 Epub 20231012. 10.3389\/fimmu.2023.1284293","journal-title":"Front Immunol"},{"issue":"1","key":"ref41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao Z","year":"2024","unstructured":"Tao Z, Chyra Z, Kotulov\u00e1 J, Celichowski P, Mih\u00e1lyov\u00e1 J, Charv\u00e1tov\u00e1 S, H\u00e1jek R (2024) Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies. Blood Cancer J 14(1):213. 10.1038\/s41408-024-01193-6","journal-title":"Blood Cancer J"},{"issue":"5","key":"ref42","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.4110\/in.2023.23.e41","article-title":"The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer","volume":"23","author":"Topchyan P","year":"2023","unstructured":"Topchyan P, Lin S, Cui W (2023) The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer. Immune Netw 23(5):e41 Epub 20231023. 10.4110\/in.2023.23.e41","journal-title":"Immune Netw"},{"issue":"10","key":"ref43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99048","article-title":"Glioblastoma-targeted CD4\u2009+\u2009CAR T cells mediate superior antitumor activity","volume":"3","author":"Wang D","year":"2018","unstructured":"Wang D, Aguilar B, Starr R, Alizadeh D, Brito A, Sarkissian A, Ostberg JR, Forman SJ, Brown CE (2018) Glioblastoma-targeted CD4\u2009+\u2009CAR T cells mediate superior antitumor activity. JCI insight 3(10). 10.1172\/jci.insight.99048","journal-title":"JCI insight"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.21037\/tcr-23-2044","article-title":"The role of CD4\u2009+\u2009CAR T cells in cancer immunotherapy","volume":"13","author":"Bove C","year":"2024","unstructured":"Bove C, Maher J, Glover M (2024) The role of CD4\u2009+\u2009CAR T cells in cancer immunotherapy. Translational Cancer Res 13(5):2580\u20132586","journal-title":"Translational Cancer Res"},{"issue":"6","key":"ref45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ni.2038","article-title":"Origins of CD4\u2009+\u2009effector and central memory T cells","volume":"12","author":"Pepper M","year":"2011","unstructured":"Pepper M, Jenkins MK (2011) Origins of CD4\u2009+\u2009effector and central memory T cells. Nat Immunol 12(6):467\u2013471. 10.1038\/ni.2038","journal-title":"Nat Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy","author":"Basu A","year":"2021","unstructured":"Basu A, Ramamoorthi G, Albert G, Gallen C, Beyer A, Snyder C, Koski G, Disis ML, Czerniecki BJ, Kodumudi K (2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Front Immunol 12\u20132021. 10.3389\/fimmu.2021.669474","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61427-4","author":"Barisa M","year":"2025","unstructured":"Barisa M, Muller HP, Zappa E, Shah R, Buhl JL, Draper B, Himsworth C, Bowers C, Munnings-Tomes S, Nicolaidou M, Morlando S, Birley K, Leboreiro-Babe C, Vitali A, Privitera L, O\u2019Sullivan K, Greppi A, Buschhaus M, Rom\u00e1n MB, de Blank S, van den Ham F, van \u2018 BR, Ferry G, Fisher J, Shome D, Nadafi R, Ansari IH, Reijmers R, Giuliani S, Sondel P, Donovan LK, Chesler L, Jan M, Drost J, Rios AC, Chester K, Wienke J, Anderson J (2025) Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. Nature Communications. ;16(1):7196. 10.1038\/s41467-025-61427-4"},{"issue":"10","key":"ref48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.trecan.2025.06.008","article-title":"IL-18 revives dysfunctional CAR-T cells","volume":"11","author":"Li Y-R","year":"2025","unstructured":"Li Y-R, Zhu Y, Yang L (2025) IL-18 revives dysfunctional CAR-T cells. Trends Cancer 11(10):923\u2013926. https:\/\/doi.org\/10.1016\/j.trecan.2025.06.008","journal-title":"Trends Cancer"},{"issue":"Suppl 1","key":"ref49","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1471-2105-7-s1-s7","article-title":"ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","volume":"7","author":"Margolin AA","year":"2006","unstructured":"Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, Califano A (2006) ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7(Suppl 1):S7 Epub 20060320. 10.1186\/1471-2105-7-s1-s7","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"ref50","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/bioinformatics\/bty907","article-title":"SJARACNe: a scalable software tool for gene network reverse engineering from big data","volume":"35","author":"Khatamian A","year":"2019","unstructured":"Khatamian A, Paull EO, Califano A, Yu J (2019) SJARACNe: a scalable software tool for gene network reverse engineering from big data. Bioinformatics 35(12):2165\u20132166. 10.1093\/bioinformatics\/bty907PubMed PMID: 30388204; PMCID: PMC6581437","journal-title":"Bioinformatics"},{"issue":"3","key":"ref51","first-page":"472","article-title":"Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc","volume":"130","author":"Friedman HS","year":"1988","unstructured":"Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Brodeur GM, He XM, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC et al (1988) Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 130(3):472\u2013484 PubMed PMID: 3279793; PMCID: PMC1880676","journal-title":"Am J Pathol"},{"issue":"3","key":"ref52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11060-012-0978-1","article-title":"HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment","volume":"110","author":"Milde T","year":"2012","unstructured":"Milde T, Lodrini M, Savelyeva L, Korshunov A, Kool M, Brueckner LM, Antunes ASLM, Oehme I, Pekrun A, Pfister SM, Kulozik AE, Witt O, Deubzer HE (2012) HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment. J Neurooncol 110(3):335\u2013348. 10.1007\/s11060-012-0978-1","journal-title":"J Neurooncol"},{"issue":"6","key":"ref53","first-page":"833","article-title":"Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts","volume":"64","author":"He XM","year":"1991","unstructured":"He XM, Wikstrand CJ, Friedman HS, Bigner SH, Pleasure S, Trojanowski JQ, Bigner DD (1991) Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 64(6):833\u2013843 PubMed PMID: 1904513","journal-title":"Lab Invest"},{"issue":"7","key":"ref54","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41592-022-01507-1","article-title":"TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines","volume":"19","author":"Ershov D","year":"2022","unstructured":"Ershov D, Phan M-S, Pylv\u00e4n\u00e4inen JW, Rigaud SU, Le Blanc L, Charles-Orszag A, Conway JRW, Laine RF, Roy NH, Bonazzi D, Dum\u00e9nil G, Jacquemet G, Tinevez J-Y (2022) TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat Methods 19(7):829\u2013832. 10.1038\/s41592-022-01507-1","journal-title":"Nat Methods"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8863171\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8863171\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:27:34Z","timestamp":1772573254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8863171\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":54,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8863171\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,2,19]]},"subtype":"preprint"}}